EGFR and lung carcinoma: While EGFR is activated by phosphorylation in 20% of cervical cancers [10], no mutations have been demonstrated so far to our knowledge, which is very different from lung cancer which harbours close to 20% (559/2880) mutations in the EGFR kinase domain [40].